NFKB1 and colonic neoplasm: Additionally, butyrate decreased the transcription of pro-inflammatory genes, such as NF-κB, in the primary epithelial cells of the human small intestine and colon, as well as the nuclear translocation of NF-κB and DNA binding in colon cancer cells [48,49].